The influence of simvastatin on lipase and cholesterol esterase activity in the serum of men with coronary heart disease

Pharmacological Research

Volumn 43, Issue 4, 2001, Pages 359-362

  Pioruńska Stolzmann, Maria ^a   Pioruńska Mikołajczak, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

CHD men; Cholesterol esterase; Lipase; Serum; Simvastatin

Indexed keywords

ACYLGLYCEROL LIPASE; CHOLESTEROL ESTERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HYPOCHOLESTEROLEMIA; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; PROTEIN CONTENT;

EID: 0034964747     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2000.0787     Document Type: Article

References (28)

1. Current perspectives on statins
2. Current aspects of statins
3. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study
4. Comparison of statins in hypertrigliceridemia
5. Comparative dose efficacy of atorvastatin versus simvastatin, pravastatin, Iovastatin, and fluvastatin in patients with hypercholesterolemia
6. Lipoprotein correlates of LDL particle size
7. Triglyceride-rich lipoproteins: Are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype?
8. Two different views of the relationship of hypertriglyceridemia to coronary heart disease
9. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
10. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipidemic men and women
11. Lipolytic enzymes and plasma lipoprotein metabolism
12. Lipoprotein metabolism in the macrophage. Implications for cholesterol deposition in atherosclerosis
13. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells
14. Cholesterol-mediated changes of neutral cholesterol esterase activity in macrophages. Mechanism for mobilization of cholesteryl esters in lipid droplets by HDL
15. Plasma cholesterol esterase levei is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects
16. The arterial acyl-CoA cholesterol ester hydrolase activities. In vitro effect of substrates with fatty acids of different chain length and saturation
17. Protein measurement with the folin phenol reagent
18. Effect of substrate composition and concentration on aortic cholesteroI ester hydrolase activity
19. The substrate specificity of glycerol ester hydrolase from pig aorta and serum
20. Antiatherothrombotic properties of statins. Implications for cardiovascular event reduction
21. Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin
22. Direct effects of statins on the vascular wall
23. HMG-CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase
24. Effects of simvastatin on apoB metabolism and LDL subfraction distribution
25. Pharmacodynamic and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences
26. The pathogenesis of atherosclerosis: A perspective for the 1990s
27. HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit
28. Differential cholesteryl ester accumulation in two human vascular smooth muscle cell subpopulations exposed to aggregated LDL: Effect of PDGF-stimulation and HMG-CoA reductase inhibition